Topic

Ultomiris (ravulizumab)

A collection of 24 issues

How to Get Ultomiris (ravulizumab) Covered by UnitedHealthcare in New Jersey: Coding, Appeals, and Step Therapy Exceptions

Answer Box: Getting Ultomiris Covered by UnitedHealthcare in New Jersey Ultomiris (ravulizumab) requires prior authorization from UnitedHealthcare in New Jersey, with step therapy typically requiring eculizumab (Soliris) or biosimilars first. To get approval: 1) Submit PA with proper ICD-10 codes (D59.5 for PNH, D59.3 series for aHUS), HCPCS

Aetna (CVS Health) Coverage Criteria for Ultomiris (ravulizumab) in New York: What Counts as "Medically Necessary"?

Answer Box: Getting Ultomiris Covered by Aetna (CVS Health) in New York Ultomiris (ravulizumab) requires prior authorization from Aetna (CVS Health) for all FDA-approved indications (PNH, aHUS, anti-AChR+ generalized myasthenia gravis, and NMOSD). Coverage requires meeting diagnosis-specific criteria, meningococcal vaccination, and documentation of clinical necessity. Quick start: 1) Verify your

Ultomiris (Ravulizumab) Approval with UnitedHealthcare in Virginia: Answers to the Most Common Questions

Answer Box: Getting Ultomiris Covered by UnitedHealthcare in Virginia UnitedHealthcare requires prior authorization for Ultomiris (ravulizumab) with step therapy typically mandating prior eculizumab trial first. Submit PA via UnitedHealthcare provider portal with diagnosis confirmation, REMS vaccination records, and clinical rationale. Standard decisions take up to 72 hours; expedited reviews (when

How to Get Ultomiris (Ravulizumab) Covered by Humana in Texas: Coding, Appeals, and Prior Authorization Guide

Answer Box: Getting Ultomiris Covered by Humana in Texas Ultomiris (ravulizumab) requires prior authorization from Humana Medicare Advantage plans in Texas. The fastest path to approval: 1) Submit PA request through Humana's provider portal with diagnosis-specific ICD-10 codes (D59.5 for PNH, D59.3 for aHUS, G70.0

Getting Ultomiris (Ravulizumab) Covered by Aetna CVS Health in California: Forms, Appeals, and Alternative Options

Answer Box: Fast Track to Ultomiris Coverage To get Ultomiris (ravulizumab) covered by Aetna CVS Health in California: Submit the Ultomiris Precertification Request form with complete clinical documentation showing FDA-approved indication, failed alternatives, and vaccination records. If denied, file internal appeal within 60 days, then request California Independent Medical Review

How to Get Ultomiris (Ravulizumab) Covered by Blue Cross Blue Shield in Michigan: Prior Authorization Forms, Timelines, and Appeals Guide

Answer Box: Quick Path to Ultomiris Approval in Michigan Blue Cross Blue Shield of Michigan requires prior authorization for Ultomiris (ravulizumab) under the medical benefit, with new step therapy requirements as of 2024. For commercial members, you must try an alternative therapy first; Medicare Advantage members need rituximab biosimilar trial

How to Get Ultomiris (Ravulizumab) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Coverage Guide

Answer Box: Getting Ultomiris Covered by Blue Cross Blue Shield in Pennsylvania To get Ultomiris (ravulizumab) covered by Blue Cross Blue Shield in Pennsylvania: 1) Confirm your diagnosis meets FDA criteria (PNH, aHUS, gMG, or NMOSD) with required lab tests, 2) Complete meningococcal vaccination and REMS enrollment, 3) Submit prior

How to Get Ultomiris (Ravulizumab) Covered by Cigna in Illinois: Complete PA Guide and Appeal Process

Quick Answer: Getting Ultomiris Covered by Cigna in Illinois Ultomiris requires prior authorization from Cigna for all conditions (PNH, aHUS, gMG, NMOSD). Submit the official Cigna PA form with complete diagnosis documentation, specialist involvement, and vaccination records. Most requests are processed within 5-7 business days. If denied, you have 180

How to Get Ultomiris (Ravulizumab) Covered by Humana in New York: Coding, Appeals, and Prior Authorization Guide

Answer Box: Getting Ultomiris Covered by Humana in New York Ultomiris (ravulizumab) requires prior authorization from Humana Medicare Advantage plans in New York. The fastest path to approval involves proper medical coding (ICD-10: D59.5 for PNH, HCPCS: J1303 for billing), comprehensive clinical documentation, and understanding New York's

How to Get Ultomiris (Ravulizumab) Approved by Cigna in New York: Complete Guide to Coverage and Appeals

Answer Box: Getting Ultomiris Covered by Cigna in New York Cigna requires prior authorization for Ultomiris (ravulizumab) in New York for all FDA-approved conditions: PNH, aHUS, generalized myasthenia gravis, and NMOSD. The fastest path to approval: Have your specialist complete Cigna's Ultomiris PA form with complete diagnosis documentation,